Medical Device and Diagnostics
News & Jobs
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile


Bracco Diagnostics Inc. 

107 College Road East

Princeton  New Jersey  08540  U.S.A.
Phone: 609-514-2200 Fax: 609-514-2424


 Company News
Bracco Diagnostics Inc. Creates First And Only U.S. FDA-Approved Multi-Dose Compliant Contrast Medium As Breakthrough Solution For Point-Of-Care Use In The CT Suite 11/24/2014 6:41:21 AM
Bracco Diagnostics Inc. Release: FDA Approves A New Ultrasound Imaging Agent 10/14/2014 7:59:27 AM
Nordion International Signs Two-Year Strontium-82 Supply Contract With Bracco Diagnostics Inc. 3/4/2014 10:04:30 AM
Emergent BioSolutions (EBS) Closes on Its Acquisition of Healthcare Protective Products Division From Bracco Diagnostics Inc. 8/2/2013 9:34:09 AM
Why Emergent BioSolutions (EBS) Paid $26 Million for Anti-Chem Lotion From Bracco Diagnostics Inc. 4/26/2013 7:47:49 AM
Bracco Diagnostics Inc. Recalls Isovue PFS Injector Syringes 11/28/2012 6:38:12 AM
FDA Approves Use of Bracco Diagnostics Inc.'s MultiHance Injection in MRA 7/30/2012 7:48:17 AM
Bracco Diagnostics Inc. Receives U.S. FDA Approval for Expanded Labeling of MultiHance® (gadobenate dimeglumine) Injection in Magnetic Resonance Angiography 7/27/2012 10:02:47 AM
MRI Contrast Agents Go Head-to-Head: Researchers Find Greater Morphologic Information and Lesion Enhancement with Bracco Diagnostics Inc.’s MultiHance® (gadobenate dimeglumine) Injection, 529 mg/mL When Compared to Gadavist™ (gadobutrol injection) 3/7/2012 10:00:18 AM
Bracco Diagnostics Inc. Resumes CardioGen-82 Shipments With New FDA-issued Box Warning Attached 2/17/2012 9:10:26 AM